ADIM
BNGO icon

Alpha DNA Investment Management’s Bionano Genomics BNGO Stock Holding History

Alpha DNA Investment Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$3K – 166
2021
Q1 		$3K Buy
+1
New +$5.64K ﹤0.01% 452

Other funds holding BNGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $38.6B AUM 35.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Alpha DNA Investment Management's BNGO Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Bionano Genomics (BNGO) in Q2 2021, closing a stake of 1 share — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in BNGO in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 152 funds tracked by Wall St. Rank hold BNGO as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Bionano Genomics position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 1 Bionano Genomics share in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in Bionano Genomics in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Bionano Genomics position peaked at $3K in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.